Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | ACE | P12821 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13248904 | 1.00 | RECQL (0.41) | RECQLGAAALDH1A1GLAHPGD | |
| SCHEMBL13248935 | 0.82 | RECQL (0.41) | RECQLALDH1A1GLAHPGDESR2 | |
| SCHEMBL3113944 | 0.82 | RECQL (0.41) | RECQLALDH1A1GLAHPGDESR2 | |
| SCHEMBL13069241 | 0.82 | RECQL (0.41) | RECQLALDH1A1GLAHPGDESR2 | |
| SCHEMBL17756759 | 0.82 | RECQL (0.41) | RECQLALDH1A1GLAHPGDESR2 | |
| SCHEMBL28044031 | 0.81 | MGLL (0.37) | RECQLGAAALDH1A1GLAHPGD | |
| Hydrochloric Acid SCHEMBL3113711 | 0.80 | ALDH1A1 (0.40) | RECQLGAAALDH1A1GLAHPGD | |
| SCHEMBL17039163 | 0.80 | RECQL (0.39) | RECQLALDH1A1GLAHPGDESR2 | |
| SCHEMBL17244066 | 0.78 | RECQL (0.38) | RECQLALDH1A1GLAHPGDESR2 | |
| SCHEMBL13069236 | 0.78 | RECQL (0.38) | RECQLALDH1A1GLAHPGDESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170146544-A1 | MASS SPECTROMETRIC QUANTITATION | ELECTROPHORETICS LIMITED (GB) | 2017-05-25 | — | — | US | disclosed |
| EP-2467350-B1 | MASS LABELS | ELECTROPHORETICS LTD (GB) | 2015-11-11 | — | — | EP | disclosed |
| US-20150065392-A1 | MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2015-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150065392-A1 | MASS LABELS | SRMS, PTMS, B2M | RECQL 2829/4885GAA 2359/4885ALDH1A1 2559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.